Atorvastatin Calcium
80 mg · Tablet
- Prescription only
- HMG-CoA Reductase Inhibitor
- Active substance
- Atorvastatin Calcium
- Made by
- Macleods Pharmaceuticals Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Atorvastatin calcium). It describes the substance, not this exact product.
Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol.
In animal models, atorvastatin calcium lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and by increasing the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL; atorvastatin calcium also reduces LDL production and the number of LDL particles.
Atorvastatin is extensively metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products.
Atorvastatin and its metabolites are eliminated primarily in bile following hepatic and/or extra-hepatic metabolism; however, the drug does not appear to undergo enterohepatic recirculation.
Although food decreases the rate and extent of drug absorption by approximately 25% and 9%, respectively, as assessed by Cmax and AUC, LDL-C reduction is similar whether atorvastatin is given with or without food.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-08-28
Safety of the active substance
From the US prescribing label for the same active substance (Atorvastatin calcium). It describes the substance, not this exact product.
- Acute liver failure or decompensated cirrhosis [see Warnings and Precautions (5.3) ] Hypersensitivity to atorvastatin or any excipients in atorvastatin calcium.
- Hypersensitivity reactions, including anaphylaxis, angioneurotic edema, erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis, have been reported [see Adverse Reactions (6.2) ].
- Hypersensitivity to atorvastatin or any excipient in atorvastatin calcium ( 4 ).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria2 matching products
Details
| Made by | Macleods Pharmaceuticals Limited |
|---|---|
| Active substance | Atorvastatin Calcium |
| Used in | Heart, blood pressure and circulation |
| Strength | 80 mg |
| Form | Tablet |
| Route | Oral |
| Packs | 90 TABLET in 1 BOTTLE · 100 TABLET in 1 BOTTLE |
| NDC | 33342-318 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
236 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Tablet, Film Coated170 products
- Tablet62 products
80 mg12
80 mg · 12 companies
- A-S Medication Solutions
- Bryant Ranch Prepack
- Dr. Reddy's Laboratories Inc
- Dr. Reddy's Laboratories Limited
- Lupin Pharmaceuticals, Inc.
- Macleods Pharmaceuticals Limited · this page
- NIVAGEN PHARMACEUTICALS, INC.
- REMEDYREPACK INC.
- Tablet, Coated4 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.